Sulfinpyrazone

FDA Approved: * September 17, 1982
Pharm Company: * BARR
Category: Gout

Sulfinpyrazone is a uricosuric medication used to treat gout. It also sometimes is used to reduce platelet aggregation by inhibiting degranulation of platelets which reduces the release of ADP and thromboxane. Like other uricosurics, sulfinpyrazone works by competitively inhibiting uric acid reabsorption in the proximal tubule of the kidney. Contraindications Sulfinpyrazone must not be used in persons with renal impairment or a history of uric acid kidney stones.[1] Re... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Related Brands

Drugs with the same active ingredients

Popular Topics

alternative to sulfinpyrazone

allergy to allopurinol and have taken sulfinpyrazole for 8 years with relief but am unablr to get it now ## That's a...

6 REPLIES